Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
Trial · NCT01560923
Adverse events222
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 222
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Positive ANA panel 1:320 | Blood and lymphatic system disorders | Sipuleucel-T + Indoximod | 1 | 22 | 1 |
| other | Positive ANA panel 1:320 | Blood and lymphatic system disorders | Sipuleucel-T + Placebo | 0 | 24 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Sipuleucel-T + Indoximod | 1 | 22 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Sipuleucel-T + Placebo | 1 | 24 | 1 |
| other | Lymph node pain (bilateral inguinal) | Blood and lymphatic system disorders | Sipuleucel-T + Indoximod | 1 | 22 | 1 |
| other | Lymph node pain (bilateral inguinal) | Blood and lymphatic system disorders | Sipuleucel-T + Placebo | 0 | 24 | 0 |
| other | White blood cell count decreased | Blood and lymphatic system disorders | Sipuleucel-T + Indoximod | 0 | 22 | 0 |
| other | White blood cell count decreased | Blood and lymphatic system disorders | Sipuleucel-T + Placebo | 1 | 24 | 1 |
| other | Atrial flutter | Cardiac disorders | Sipuleucel-T + Indoximod | 1 | 22 | 1 |
| other | Atrial flutter | Cardiac disorders | Sipuleucel-T + Placebo | 0 | 24 | 0 |
| other | Middle ear effusion | Ear and labyrinth disorders | Sipuleucel-T + Indoximod | 1 | 22 | 1 |
| other | Middle ear effusion | Ear and labyrinth disorders | Sipuleucel-T + Placebo | 0 | 24 | 0 |
| other | Ear pain | Ear and labyrinth disorders | Sipuleucel-T + Indoximod | 0 | 22 | 0 |
| other | Ear pain | Ear and labyrinth disorders | Sipuleucel-T + Placebo | 1 | 24 | 1 |
| other | Blurred vision | Eye disorders | Sipuleucel-T + Indoximod | 0 | 22 | 0 |
| other | Blurred vision | Eye disorders | Sipuleucel-T + Placebo | 2 | 24 | 2 |
| other | Watering eyes | Eye disorders | Sipuleucel-T + Indoximod | 0 | 22 | 0 |
| other | Watering eyes | Eye disorders | Sipuleucel-T + Placebo | 1 | 24 | 1 |
| other | Abdominal distension | Gastrointestinal disorders | Sipuleucel-T + Indoximod | 1 | 22 | 1 |
| other | Abdominal distension | Gastrointestinal disorders | Sipuleucel-T + Placebo | 1 | 24 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01560923/events